Leonilde Bonfrate, MD, PhD, is Associate Professor of Internal Medicine at San Raffaele Roma University, Italy. She is a board-certified specialist in Internal Medicine with established expertise in obesity and metabolic diseases. Prof. Bonfrate is Expert Consultant at the Obesity and Clinical Nutrition Center of IRCCS Saverio de Bellis (Italy), a national referral institute for gastroenterology and metabolic diseases. Her clinical and research activities focus on obesity, metabolic syndrome, metabolic-associated fatty liver disease, type 2 diabetes, and clinical nutrition, with particular emphasis on the brain–gut–liver axis and gut microbiota in metabolic dysfunction. She is widely recognized as an opinion leader in obesity and metabolic disorders. She is author and co-author of 90 peer-reviewed publications in international high-impact journals, with 4,523 citations. Prof. Bonfrate serves as Councillor of the European Society of Clinical Investigation (ESCI), Section Editor of the European Journal of Clinical Investigation, and President of the ESCI Journal Foundation. She is an active member of numerous national and international scientific societies and working groups in the fields of internal medicine, obesity, metabolic diseases, and clinical investigation. She regularly participates in major European and international congresses and has delivered numerous invited lectures in her areas of expertise.

João Conde is a Full Professor of Precision Medicine and Oncogenomics at NOVA Medical School and the Comprehensive Health Research Centre, Universidade NOVA de Lisboa. His work bridges oncogenomics, nanomedicine and gene therapy, with a strong emphasis on precision oncology and translational biomedicine. He earned his PhD in NanoBiotechnology in 2013 through a joint programme between Universidade NOVA de Lisboa and Universidad de Zaragoza, and later held Marie Curie fellowships at MIT, the Harvard-MIT Division for Health Sciences and Technology, and Queen Mary University of London. In 2019, he received a European Research Council Starting Grant to develop genetic biobarcodes for breast cancer heterogeneity. He is co-founder of TargTex, a biotech company focused on targeted therapies for glioblastoma, and has contributed to the Global Burden of Disease Consortium since 2020. Conde has published over 170 articles, holds 12 patents, and has received several international distinctions for scientific excellence and innovation.